Baroreflex Activation Therapy for Heart Failure | Clinical Trial - BAT for HFrEF

Description:

The goal of the trial was to compare the safety and efficacy of BAT in patients with chronic systolic heart failure (HF).

Contribution to the Literature: This pilot study suggests that baroreflex activation therapy may provide symptomatic benefit in patients with chronic systolic HF.